WASHINGTON, Aug 26 (Reuters) - U.S. regulators have warned Novartis AG’s generic drug unit Sandoz about manufacturing problems at a North Carolina plant, a letter released on Tuesday said.
WASHINGTON, Aug 26 (Reuters) - U.S. regulators have warned Novartis AG’s generic drug unit Sandoz about manufacturing problems at a North Carolina plant, a letter released on Tuesday said.
